$Evaluating the antifracture efficacy of bisphosphonates.$

Evaluating the antifracture efficacy of bisphosphonates.

Oral bisphosphonate dosing schedules have evolved from the original daily regimens to weekly (alendronate and risedronate) and monthly (risedronate and ibandronate) regimens. Intravenous (i.v.) bisphosphonates are administered less frequently-quarterly ibandronate injection and yearly zoledronic aci...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Pazianas, M, Epstein, S, Zaidi, M
Формат:	Journal article
Хэл сонгох:	English
Хэвлэсэн:	2009

Ижил төстэй зүйлс

Antifracture agents for prostate cancer patients on androgen deprivation therapy
-н: Bhupendra P Singh, зэрэг
Хэвлэсэн: (2010-01-01)

The sequential antifracturative treatment: a meta-analysis of randomized clinical trials
-н: Angelo Fassio, зэрэг
Хэвлэсэн: (2024-04-01)

Safety of bisphosphonates.
-н: Pazianas, M, зэрэг
Хэвлэсэн: (2011)

Bisphosphonates and bone quality.
-н: Pazianas, M, зэрэг
Хэвлэсэн: (2014)

Atrial fibrillation and bisphosphonate therapy.
-н: Pazianas, M, зэрэг
Хэвлэсэн: (2010)

Potential therapeutic effects of oral bisphosphonates on the intestine.
-н: Pazianas, M, зэрэг
Хэвлэсэн: (2011)

Safety issues with bisphosphonate therapy for osteoporosis.
-н: Suresh, E, зэрэг
Хэвлэсэн: (2014)

Are bisphosphonates associated with an increased risk of atypical femoral fractures as a class?
-н: Pazianas, M
Хэвлэсэн: (2013)

Cardiovascular Safety of Antifracture Medications in Patients With Osteoporosis: A Narrative Review of Evidence From Randomized Studies
-н: Alexander J Rodríguez, зэрэг
Хэвлэсэн: (2022-06-01)

Cardiovascular Safety of Antifracture Medications in Patients With Osteoporosis: A Narrative Review of Evidence From Randomized Studies
-н: Alexander J Rodríguez, зэрэг
Хэвлэсэн: (2021-07-01)

Bisphosphonates and colon cancer: reply.
-н: Pazianas, M, зэрэг
Хэвлэсэн: (2013)

Bisphosphonates and colon cancer: Reply
-н: Pazianas, M, зэрэг
Хэвлэсэн: (2013)

Eliminating the need for fasting with oral administration of bisphosphonates.
-н: Pazianas, M, зэрэг
Хэвлэсэн: (2013)

Eliminating the need for fasting with oral administration of bisphosphonates
-н: Pazianas M, зэрэг
Хэвлэсэн: (2013-10-01)

NE‐58025: A bisphosphonate with a low hydroxyapatite binding affinity
-н: Michael Pazianas
Хэвлэсэн: (2021-08-01)

Atrial fibrillation and the use of oral bisphosphonates.
-н: Pazianas, M, зэрэг
Хэвлэсэн: (2011)

Atrial fibrillation and the use of oral bisphosphonates
-н: Michael Pazianas, зэрэг
Хэвлэсэн: (2011-03-01)

Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis.
-н: Pazianas, M, зэрэг
Хэвлэсэн: (2010)

Findings of Danish study on risk of colon cancer in bisphosphonate users were misinterpreted.
-н: Abrahamsen, B, зэрэг
Хэвлэсэн: (2013)

NO ASSOCIATION BETWEEN THE USE OF ORAL BISPHOSPHONATES AND INCIDENCE OF ATRIAL FIBRILLATION
-н: Pazianas, M, зэрэг
Хэвлэсэн: (2010)

Comment on Tadrous et al.: comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis.
-н: Pazianas, M, зэрэг
Хэвлэсэн: (2014)

Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker.
-н: Pazianas, M, зэрэг
Хэвлэсэн: (2008)

Lack of association between oral bisphosphonates and osteonecrosis using jaw surgery as a surrogate marker: Reply to Yarom and Elad
-н: Pazianas, M, зэрэг
Хэвлэсэн: (2008)

A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
-н: Pazianas, M, зэрэг
Хэвлэсэн: (2007)

Impact of bisphosphonates in age-related macular degeneration: Retrospective cohort and nested case-control study
-н: Garriga, C, зэрэг
Хэвлэсэн: (2018)

Reduced colon cancer incidence and mortality in postmenopausal women treated with an oral bisphosphonate--Danish National Register Based Cohort Study.
-н: Pazianas, M, зэрэг
Хэвлэсэн: (2012)

Inflammatory eye reactions in patients treated with bisphosphonates and other osteoporosis medications: cohort analysis using a national prescription database.
-н: Pazianas, M, зэрэг
Хэвлэсэн: (2013)

Oral bisphosphonate use and age-related macular degeneration: retrospective cohort and nested case-control study
-н: Garriga, C, зэрэг
Хэвлэсэн: (2018)

Impact of bisphosphonate use and age-related macular degeneration: retrospective cohort and nested case-control study
-н: Garriga, C, зэрэг
Хэвлэсэн: (2018)

Bisphosphonates and Age-Related Macular Degeneration: A Propensity-Matched Cohort and Nested Case-Control Analysis
-н: Garriga, C, зэрэг
Хэвлэсэн: (2017)

Bisphosphonates
-н: Bishop, N, зэрэг
Хэвлэсэн: (2013)

Bisphosphonates
-н: Fırat Öztürk
Хэвлэсэн: (2009-04-01)

Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy.
-н: Russell, R, зэрэг
Хэвлэсэн: (2007)

Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy.
-н: Russell, R, зэрэг
Хэвлэсэн: (2007)

Safety and efficacy of bisphosphonates in thalassemia patients with osteopenia/osteoporosis
-н: Sujata Sharma, зэрэг
Хэвлэсэн: (2023-04-01)

Efficacy of Bisphosphonates for the Treatment of Osteoporosis in Patients with Multiple Sclerosis
-н: İlke Coşkun Benlidayı, зэрэг
Хэвлэсэн: (2015-08-01)

Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy.
-н: Russell, R, зэрэг
Хэвлэсэн: (2008)

Bisphosphonates: An update
-н: Nalliappan Ganapathy, зэрэг
Хэвлэсэн: (2012-01-01)

Bisphosphonates 2006
-н: Russell, R
Хэвлэсэн: (2006)

Incidence of fractures of the femur, including subtrochanteric, up to 8 years since initiation of oral bisphosphonate therapy: a register-based cohort study using the US MarketScan claims databases.
-н: Pazianas, M, зэрэг
Хэвлэсэн: (2012)